Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dentin sialophosphoprotein (DSPP) is a large, chimeric precursor protein belonging to the SIBLING (Small Integrin-Binding Ligand, N-linked Glycoprotein) family, primarily expressed by odontoblasts during tooth development (PMC3576053, Wikipedia). It is essential for the biomineralization of dentin, where it is proteolytically cleaved into three active fragments: dentin sialoprotein (DSP), dentin glycoprotein (DGP), and dentin phosphoprotein (DPP) (PMC3372502, PMC4100609). These fragments work in concert to regulate the nucleation and growth of hydroxyapatite crystals, converting predentin into mineralized dentin (PMC3421774). Mutations in the DSPP gene are the underlying cause of hereditary dental disorders such as dentinogenesis imperfecta and dentin dysplasia, leading to severely weakened tooth structures and premature tooth loss (PMC3576053). In the field of regenerative dentistry, DSPP serves as a critical therapeutic target; bioactive materials like Mineral Trioxide Aggregate (MTA) and experimental small molecules such as GSK3 inhibitors are utilized to stimulate its expression and induce reparative dentin formation (PMC7464817, PMC5510624). Consequently, DSPP is regarded as a primary biomarker for odontoblast differentiation and a focal point for developing dental tissue engineering strategies (PMC5510624, PMC4131557).
Stimulation of odontoblast differentiation and promotion of DSPP-mediated hydroxyapatite crystal nucleation and growth for reparative dentinogenesis.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin sialophosphoprotein (DSPP) (DSPP).